Bruker BRKR NASDAQ · Healthcare · United States
$62.41 +0.27% +$0.17
Summary
31 / 100 · Bulios Score
What speaks for it
- Revenue grew by 11% a year over the last 3 years.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 12.9 years of operating profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBy our assumptions the price matches the value of the business: the two differ by less than 10 %.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 11% a year. For the next fiscal year analysts expect revenue to grow by 3.1%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $123.4M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 0.32%
You receive $0.20 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 16
- Hold 15
- Sell 2
Today's price within the analysts' price targets
The average target of $67 is 7.4% above today's price. 48% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product 81%
- Product and Service, Other 19%
By region
- Europe Excluding Germany 28%
- UNITED STATES 26%
- Asia Pacific Excluding China 16%
- CHINA 14%
- GERMANY 8.6%
- Other 7.8%
Product brings in 81% of revenue. Product and Service, Other grew fastest, by 208% a year.
Segments in detail